GSK Investors Urged to Act Before Critical Deadline as Rosen Law Firm Investigates Allegations of Securities Violations
ROSEN LAW FIRM REMINDS GSK INVESTORS WITH LOSSES IN EXCESS OF $100K OF DEADLINE IN SECS CLASS ACTION
New York, NY - Rosen Law Firm reminds investors of GSK plc (GSK) with losses in excess of $100,000 that the deadline to secure counsel is tomorrow, April 7, 2023, in securities class action.
On March 14, 2023, the Rosen Law Firm filed a securities class action on behalf of purchasers of GSK plc securities between October 25, 2018 and March 2, 2023. The lawsuit alleges that GSK made false and misleading statements about its business and financial results, causing significant harm to investors.
The Rosen Law Firm encourages investors with losses in excess of $100,000 to secure counsel by tomorrow, April 7, 2023, to protect their rights and recover their losses.
The lawsuit seeks to recover damages for GSK investors who purchased the company's securities during the class period. The plaintiff is represented by the Rosen Law Firm, a top-ranked law firm with significant experience in securities class actions.
Investors who purchased GSK securities between October 25, 2018 and March 2, 2023, and have losses in excess of $100,000, are encouraged to contact the Rosen Law Firm to discuss their options and potential recovery.
The Rosen Law Firm has a proven track record of securing significant recoveries for investors in securities class actions. The firm has been recognized as one of the top law firms in the country by various ranking organizations, including the National Law Journal and Fortune Magazine.
The Rosen Law Firm represents investors worldwide, including those in the United States, Canada, Europe, Australia, and Asia. The firm's attorneys have significant experience in securities class actions and have recovered hundreds of millions of dollars for investors.
The deadline to secure counsel is tomorrow, April 7, 2023. Investors who have losses in excess of $100,000 should contact the Rosen Law Firm as soon as possible to discuss their options and potential recovery.